Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Eisai, J&J, RDIF, Sanofi, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Berlin Heart, Canam Scientific, Clordisys Solutions, Sd Biosensor, Zymo Research.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alkermes, Astellas, Aveo, Biocryst, Biohaven, Bioxcel, Denali, Eli Lilly, J&J, Kadmon, Longeveron, Marius, Nouscom, Nuvation, RDIF, Spectrum.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akesis, Breath Direct, Clew, Datar Cancer Genetics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adaptive Phage, Amgen, Circ, Demerx, Idorsia, Kiromic, Lannett, Linnaeus, RDIF, Tarus, Vertex.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Abcellera, Beigene, Betta, Cytodyn, Eisai, Eli Lilly, Exithera, Gtreebnt, Johnson & Johnson, Junshi, Kintor, Lee's, Moderna, Nicox, Oblato, Ocumension, RDIF, Shanghai Junshi, Sorrento, Turnsole, Wellmarker.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Able Medical, Eitan Medical, Empatica, Inivata, Mahana Therapeutics, Roche.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acadia, Affibody, Alphamab, Altrubio, Amylyx, Cyclo, Huya, Inmagene, Melior, Oncopeptides, Rocket.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abcellera, Biomarin, Caladrius, Cara, Cytodyn, Gilead, J&J, Junshi, Lee's, Lilly, Nervgen, Passage, RDIF, Roche, Saniona, Sesen, Soleno, Sorrento, Steba, Tissuetech, Ultragenyx, Vifor.